272 related articles for article (PubMed ID: 32712172)
1. New and potential strategies for the treatment of PMM2-CDG.
Gámez A; Serrano M; Gallego D; Vilas A; Pérez B
Biochim Biophys Acta Gen Subj; 2020 Nov; 1864(11):129686. PubMed ID: 32712172
[TBL] [Abstract][Full Text] [Related]
2. Proteostasis regulators as potential rescuers of PMM2 activity.
Vilas A; Yuste-Checa P; Gallego D; Desviat LR; Ugarte M; Pérez-Cerda C; Gámez A; Pérez B
Biochim Biophys Acta Mol Basis Dis; 2020 Jul; 1866(7):165777. PubMed ID: 32222543
[TBL] [Abstract][Full Text] [Related]
3. Liposome-encapsulated mannose-1-phosphate therapy improves global N-glycosylation in different congenital disorders of glycosylation.
Budhraja R; Radenkovic S; Jain A; Muffels IJJ; Ismaili MHA; Kozicz T; Pandey A; Morava E
Mol Genet Metab; 2024 Jun; 142(2):108487. PubMed ID: 38733638
[TBL] [Abstract][Full Text] [Related]
4. Unsuccessful intravenous D-mannose treatment in PMM2-CDG.
Grünert SC; Marquardt T; Lausch E; Fuchs H; Thiel C; Sutter M; Schumann A; Hannibal L; Spiekerkoetter U
Orphanet J Rare Dis; 2019 Oct; 14(1):231. PubMed ID: 31640729
[TBL] [Abstract][Full Text] [Related]
5. A zebrafish model of PMM2-CDG reveals altered neurogenesis and a substrate-accumulation mechanism for N-linked glycosylation deficiency.
Cline A; Gao N; Flanagan-Steet H; Sharma V; Rosa S; Sonon R; Azadi P; Sadler KC; Freeze HH; Lehrman MA; Steet R
Mol Biol Cell; 2012 Nov; 23(21):4175-87. PubMed ID: 22956764
[TBL] [Abstract][Full Text] [Related]
6. A mouse model of a human congenital disorder of glycosylation caused by loss of PMM2.
Chan B; Clasquin M; Smolen GA; Histen G; Powe J; Chen Y; Lin Z; Lu C; Liu Y; Cang Y; Yan Z; Xia Y; Thompson R; Singleton C; Dorsch M; Silverman L; Su SM; Freeze HH; Jin S
Hum Mol Genet; 2016 Jun; 25(11):2182-2193. PubMed ID: 27053713
[TBL] [Abstract][Full Text] [Related]
7. Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice.
Schneider A; Thiel C; Rindermann J; DeRossi C; Popovici D; Hoffmann GF; Gröne HJ; Körner C
Nat Med; 2011 Dec; 18(1):71-3. PubMed ID: 22157680
[TBL] [Abstract][Full Text] [Related]
8. Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG).
Thiesler CT; Cajic S; Hoffmann D; Thiel C; van Diepen L; Hennig R; Sgodda M; Weiβmann R; Reichl U; Steinemann D; Diekmann U; Huber NM; Oberbeck A; Cantz T; Kuss AW; Körner C; Schambach A; Rapp E; Buettner FF
Mol Cell Proteomics; 2016 Apr; 15(4):1435-52. PubMed ID: 26785728
[TBL] [Abstract][Full Text] [Related]
9. Mannose supplementation in PMM2-CDG.
Taday R; Park JH; Grüneberg M; DuChesne I; Reunert J; Marquardt T
Orphanet J Rare Dis; 2021 Aug; 16(1):359. PubMed ID: 34380532
[TBL] [Abstract][Full Text] [Related]
10. Phosphomannose isomerase inhibitors improve N-glycosylation in selected phosphomannomutase-deficient fibroblasts.
Sharma V; Ichikawa M; He P; Scott DA; Bravo Y; Dahl R; Ng BG; Cosford ND; Freeze HH
J Biol Chem; 2011 Nov; 286(45):39431-8. PubMed ID: 21949237
[TBL] [Abstract][Full Text] [Related]
11. In vitro treatment of congenital disorder of glycosylation type Ia using PLGA nanoparticles loaded with GDP‑Man.
Bortot B; De Martino E; Tesser A; Ura B; Ruozi B; Aloisio M; Biffi S; Addobbati R; Tosi G; Dolcetta D; Severini GM
Int J Mol Med; 2019 Jul; 44(1):262-272. PubMed ID: 31115488
[TBL] [Abstract][Full Text] [Related]
12. Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG.
Iyer S; Sam FS; DiPrimio N; Preston G; Verheijen J; Murthy K; Parton Z; Tsang H; Lao J; Morava E; Perlstein EO
Dis Model Mech; 2019 Nov; 12(11):. PubMed ID: 31636082
[TBL] [Abstract][Full Text] [Related]
13. Dietary mannose supplementation in phosphomannomutase 2 deficiency (PMM2-CDG).
Taday R; Grüneberg M; DuChesne I; Reunert J; Marquardt T
Orphanet J Rare Dis; 2020 Sep; 15(1):258. PubMed ID: 32962735
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Chaperoning: A Potential Treatment for PMM2-CDG.
Yuste-Checa P; Brasil S; Gámez A; Underhaug J; Desviat LR; Ugarte M; Pérez-Cerdá C; Martinez A; Pérez B
Hum Mutat; 2017 Feb; 38(2):160-168. PubMed ID: 27774737
[TBL] [Abstract][Full Text] [Related]
15. The Effects of PMM2-CDG-Causing Mutations on the Folding, Activity, and Stability of the PMM2 Protein.
Yuste-Checa P; Gámez A; Brasil S; Desviat LR; Ugarte M; Pérez-Cerdá C; Pérez B
Hum Mutat; 2015 Sep; 36(9):851-60. PubMed ID: 26014514
[TBL] [Abstract][Full Text] [Related]
16. AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG).
Martínez-Monseny AF; Bolasell M; Callejón-Póo L; Cuadras D; Freniche V; Itzep DC; Gassiot S; Arango P; Casas-Alba D; de la Morena E; Corral J; Montero R; Pérez-Cerdá C; Pérez B; Artuch R; Jaeken J; Serrano M;
Ann Neurol; 2019 May; 85(5):740-751. PubMed ID: 30873657
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis revealing destabilizing mutations in phosphomannomutase 2 deficiency (PMM2-CDG): expression analysis of PMM2-CDG mutations.
Vega AI; Pérez-Cerdá C; Abia D; Gámez A; Briones P; Artuch R; Desviat LR; Ugarte M; Pérez B
J Inherit Metab Dis; 2011 Aug; 34(4):929-39. PubMed ID: 21541725
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous improvement of carbohydrate-deficient transferrin in PMM2-CDG without mannose observed in CDG natural history study.
Witters P; Edmondson AC; Lam C; Johnsen C; Patterson MC; Raymond KM; He M; Freeze HH; Morava E
Orphanet J Rare Dis; 2021 Feb; 16(1):102. PubMed ID: 33632285
[TBL] [Abstract][Full Text] [Related]
19. Yeast Models of Phosphomannomutase 2 Deficiency, a Congenital Disorder of Glycosylation.
Lao JP; DiPrimio N; Prangley M; Sam FS; Mast JD; Perlstein EO
G3 (Bethesda); 2019 Feb; 9(2):413-423. PubMed ID: 30530630
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic analysis identifies dysregulated pathways and therapeutic targets in PMM2-CDG.
Gallego D; Serrano M; Cordoba-Caballero J; Gámez A; Seoane P; Perkins JR; Ranea JAG; Pérez B
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167163. PubMed ID: 38599261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
